REVIEW article
Front. Bioeng. Biotechnol.
Sec. Biosafety and Biosecurity
Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1708724
Methodological Landscape of Retroviral and Retroviral Vector Integration Site Identification
Provisionally accepted- Research Centre for Medical Genetics, Moscow, Russia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Detailed mapping of viral vector integration sites (ISA), including retroviral and particularly lentiviral vectors, is critical for assessing their safety in preclinical and clinical studies. Although integration into the host genome follows certain virus-specific patterns, it remains a stochastic event and can cause insertional mutagenesis with diverse consequences, such as oncogene activation. In this review, we trace the evolution of ISA methods applied to retroviruses and derived vectors, from early labor-intensive approaches with limited coverage – such as combined strategies involving restriction analysis, Southern blotting, and subcloning – to modern high-throughput strategies. We discuss key methodologies that shaped the field, including inverse PCR (iPCR), ligation-mediated PCR (LM-PCR), and linear amplification-mediated PCR (LAM-PCR), highlighting their contributions to more comprehensive and unbiased mapping, as well as limitations associated with systematic errors stemming from dependence on restriction endonuclease digestion and amplification biases. We also examine recent approaches designed to overcome these limitations, independent of PCR and restriction analysis, which enable a more accurate and undistorted representation of retroviral vector integration profiles. Despite the emergence of new techniques, classical methods— particularly LAM-PCR and its modifications, such as nrLAM-PCR—remain widely used and continue to serve as the standard in many commercial platforms.
Keywords: Retroviral vectors, provirus mapping, integration site, Gene Therapy, insertional mutagenesis, Clonal expansion
Received: 19 Sep 2025; Accepted: 16 Oct 2025.
Copyright: © 2025 Kochergin-Nikitsky, Lavrov and Smirnikhina. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Konstantin Kochergin-Nikitsky, kochnik.ks@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.